An open-label study of tolerability, clinical response, and satisfaction in adult bipolar I subjects optimizing initiation of therapy using administration of dermatological precautions and Lamictal titration packs
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 25 Jun 2007 Status changed from in progress to completed.
- 01 Oct 2005 New trial record.